nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—Parkinson's disease	0.951	1	CbGaD
Ciclesonide—SERPINA6—hindbrain—Parkinson's disease	0.00388	0.118	CbGeAlD
Ciclesonide—NR3C1—nerve—Parkinson's disease	0.00227	0.069	CbGeAlD
Ciclesonide—CES1—cardiovascular system—Parkinson's disease	0.00182	0.0552	CbGeAlD
Ciclesonide—NR3C1—hindbrain—Parkinson's disease	0.0017	0.0517	CbGeAlD
Ciclesonide—CYP2D6—hindbrain—Parkinson's disease	0.00127	0.0384	CbGeAlD
Ciclesonide—CES1—head—Parkinson's disease	0.00123	0.0374	CbGeAlD
Ciclesonide—SERPINA6—head—Parkinson's disease	0.00123	0.0374	CbGeAlD
Ciclesonide—CES1—nervous system—Parkinson's disease	0.00117	0.0355	CbGeAlD
Ciclesonide—SERPINA6—nervous system—Parkinson's disease	0.00117	0.0354	CbGeAlD
Ciclesonide—CES1—central nervous system—Parkinson's disease	0.00112	0.0341	CbGeAlD
Ciclesonide—SERPINA6—central nervous system—Parkinson's disease	0.00112	0.0341	CbGeAlD
Ciclesonide—SERPINA6—cerebellum—Parkinson's disease	0.0011	0.0333	CbGeAlD
Ciclesonide—NR3C1—embryo—Parkinson's disease	0.00106	0.0323	CbGeAlD
Ciclesonide—NR3C1—brainstem—Parkinson's disease	0.000975	0.0296	CbGeAlD
Ciclesonide—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.000946	0.0582	CbGpPWpGaD
Ciclesonide—NR3C1—forebrain—Parkinson's disease	0.000941	0.0286	CbGeAlD
Ciclesonide—CES1—brain—Parkinson's disease	0.000892	0.0271	CbGeAlD
Ciclesonide—SERPINA6—brain—Parkinson's disease	0.000891	0.0271	CbGeAlD
Ciclesonide—NR3C1—cardiovascular system—Parkinson's disease	0.000796	0.0242	CbGeAlD
Ciclesonide—CYP2D6—brainstem—Parkinson's disease	0.000726	0.022	CbGeAlD
Ciclesonide—CYP2D6—forebrain—Parkinson's disease	0.0007	0.0213	CbGeAlD
Ciclesonide—NR3C1—medulla oblongata—Parkinson's disease	0.00068	0.0206	CbGeAlD
Ciclesonide—NR3C1—Nuclear Receptors—NR4A2—Parkinson's disease	0.000645	0.0397	CbGpPWpGaD
Ciclesonide—NR3C1—midbrain—Parkinson's disease	0.000621	0.0189	CbGeAlD
Ciclesonide—NR3C1—spinal cord—Parkinson's disease	0.000606	0.0184	CbGeAlD
Ciclesonide—NR3C1—head—Parkinson's disease	0.000539	0.0164	CbGeAlD
Ciclesonide—NR3C1—nervous system—Parkinson's disease	0.000511	0.0155	CbGeAlD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.00051	0.0314	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—MTHFR—Parkinson's disease	0.00051	0.0314	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—INSR—Parkinson's disease	0.000505	0.0311	CbGpPWpGaD
Ciclesonide—NR3C1—central nervous system—Parkinson's disease	0.000492	0.0149	CbGeAlD
Ciclesonide—NR3C1—cerebellum—Parkinson's disease	0.000481	0.0146	CbGeAlD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—Parkinson's disease	0.000452	0.0278	CbGpPWpGaD
Ciclesonide—CYP2D6—head—Parkinson's disease	0.000401	0.0122	CbGeAlD
Ciclesonide—NR3C1—brain—Parkinson's disease	0.00039	0.0119	CbGeAlD
Ciclesonide—CYP3A4—nervous system—Parkinson's disease	0.000386	0.0117	CbGeAlD
Ciclesonide—CES1—NRF2 pathway—GSTA4—Parkinson's disease	0.000382	0.0235	CbGpPWpGaD
Ciclesonide—CYP2D6—nervous system—Parkinson's disease	0.00038	0.0115	CbGeAlD
Ciclesonide—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000373	0.0229	CbGpPWpGaD
Ciclesonide—CYP3A4—central nervous system—Parkinson's disease	0.000372	0.0113	CbGeAlD
Ciclesonide—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00037	0.0228	CbGpPWpGaD
Ciclesonide—CYP2D6—central nervous system—Parkinson's disease	0.000366	0.0111	CbGeAlD
Ciclesonide—CYP2D6—cerebellum—Parkinson's disease	0.000358	0.0109	CbGeAlD
Ciclesonide—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000341	0.021	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.000324	0.0199	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PENK—Parkinson's disease	0.0003	0.0185	CbGpPWpGaD
Ciclesonide—CYP2D6—brain—Parkinson's disease	0.000291	0.00882	CbGeAlD
Ciclesonide—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000274	0.0169	CbGpPWpGaD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.000268	0.0165	CbGpPWpGaD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000263	0.0162	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000245	0.0151	CbGpPWpGaD
Ciclesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000244	0.015	CbGpPWpGaD
Ciclesonide—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000229	0.0141	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—NQO1—Parkinson's disease	0.000229	0.0141	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HSPA1A—Parkinson's disease	0.000227	0.014	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—SLC6A3—Parkinson's disease	0.000226	0.0139	CbGpPWpGaD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000221	0.0136	CbGpPWpGaD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000196	0.0121	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—GSTP1—Parkinson's disease	0.000191	0.0118	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HMOX1—Parkinson's disease	0.000188	0.0116	CbGpPWpGaD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000179	0.011	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—GSTM1—Parkinson's disease	0.000176	0.0108	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HGF—Parkinson's disease	0.000176	0.0108	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000164	0.0101	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TH—Parkinson's disease	0.000162	0.00997	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000161	0.00992	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.000159	0.00981	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000158	0.0097	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000153	0.00941	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Parkinson's disease	0.000153	0.00941	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00015	0.00922	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000144	0.00887	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00014	0.00862	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000135	0.00831	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000135	0.00828	CbGpPWpGaD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000133	0.0082	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000131	0.00803	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.000128	0.0079	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.000127	0.00784	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000124	0.0076	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—Parkinson's disease	0.000121	0.00745	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000114	0.00698	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000113	0.00697	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000106	0.00653	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000103	0.00633	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	9.91e-05	0.0061	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	9.81e-05	0.00603	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Parkinson's disease	9.77e-05	0.00601	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	9.76e-05	0.006	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	9.52e-05	0.00586	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	9.4e-05	0.00578	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NR4A2—Parkinson's disease	8.81e-05	0.00542	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TH—Parkinson's disease	8.53e-05	0.00525	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	8.04e-05	0.00494	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	7.72e-05	0.00475	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	7.7e-05	0.00474	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	7.65e-05	0.00471	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	7.57e-05	0.00466	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	7.42e-05	0.00457	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	7.2e-05	0.00443	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	6.95e-05	0.00428	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	6.81e-05	0.00419	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	6.77e-05	0.00416	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	6.72e-05	0.00413	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	6.67e-05	0.00411	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.35e-05	0.00391	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	6.22e-05	0.00383	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	6.17e-05	0.00379	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	6.14e-05	0.00378	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	6.03e-05	0.00371	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PRKRA—Parkinson's disease	6.02e-05	0.0037	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	5.87e-05	0.00361	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	5.52e-05	0.00339	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—INS—Parkinson's disease	5.4e-05	0.00332	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	5.34e-05	0.00328	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	5.05e-05	0.0031	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	4.42e-05	0.00272	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	4.36e-05	0.00268	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TAF1—Parkinson's disease	4.24e-05	0.00261	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NR4A2—Parkinson's disease	4.24e-05	0.00261	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	4.15e-05	0.00255	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	4.1e-05	0.00252	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.04e-05	0.00249	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CTGF—Parkinson's disease	3.97e-05	0.00244	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	3.94e-05	0.00243	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—Parkinson's disease	3.87e-05	0.00238	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	3.48e-05	0.00214	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	3.47e-05	0.00214	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	3.41e-05	0.0021	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—COMT—Parkinson's disease	3.4e-05	0.00209	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL6—Parkinson's disease	3.39e-05	0.00209	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	3.38e-05	0.00208	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	3.37e-05	0.00207	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	3.35e-05	0.00206	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	3.33e-05	0.00205	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	3.11e-05	0.00191	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	3.06e-05	0.00188	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.93e-05	0.0018	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—Parkinson's disease	2.92e-05	0.0018	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	2.89e-05	0.00178	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	2.68e-05	0.00165	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.64e-05	0.00163	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL23A—Parkinson's disease	2.57e-05	0.00158	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL14—Parkinson's disease	2.57e-05	0.00158	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.53e-05	0.00155	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS8—Parkinson's disease	2.4e-05	0.00147	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—Parkinson's disease	2.36e-05	0.00145	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.22e-05	0.00137	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.21e-05	0.00136	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.21e-05	0.00136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ND3—Parkinson's disease	2.2e-05	0.00136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.2e-05	0.00136	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.19e-05	0.00135	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.18e-05	0.00134	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.07e-05	0.00127	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—OMD—Parkinson's disease	2.07e-05	0.00127	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.04e-05	0.00125	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.03e-05	0.00125	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2e-05	0.00123	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.96e-05	0.00121	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA8—Parkinson's disease	1.92e-05	0.00118	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CTGF—Parkinson's disease	1.91e-05	0.00118	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.87e-05	0.00115	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	1.75e-05	0.00108	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DBH—Parkinson's disease	1.67e-05	0.00103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.67e-05	0.00103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GBA—Parkinson's disease	1.67e-05	0.00103	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.44e-05	0.000886	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ND3—Parkinson's disease	1.44e-05	0.000886	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.35e-05	0.000833	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—OMD—Parkinson's disease	1.35e-05	0.000833	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.28e-05	0.00079	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DDC—Parkinson's disease	1.23e-05	0.000754	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.22e-05	0.000753	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.16e-05	0.000712	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.09e-05	0.000671	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DBH—Parkinson's disease	1.09e-05	0.000671	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GBA—Parkinson's disease	1.09e-05	0.000671	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.04e-05	0.000641	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.03e-05	0.000634	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DDC—Parkinson's disease	8.01e-06	0.000493	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	7.57e-06	0.000465	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CTGF—Parkinson's disease	7.52e-06	0.000463	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	7.01e-06	0.000431	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NQO1—Parkinson's disease	6.93e-06	0.000426	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TH—Parkinson's disease	6.83e-06	0.00042	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	6.81e-06	0.000419	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MAOB—Parkinson's disease	6.74e-06	0.000415	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYCS—Parkinson's disease	6.56e-06	0.000404	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COMT—Parkinson's disease	5.81e-06	0.000357	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	5.78e-06	0.000356	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MAOA—Parkinson's disease	5.77e-06	0.000355	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	5.7e-06	0.000351	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	5.47e-06	0.000337	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	5.31e-06	0.000327	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.09e-06	0.000313	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.01e-06	0.000308	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.92e-06	0.000303	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	4.7e-06	0.000289	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.58e-06	0.000282	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.53e-06	0.000279	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TH—Parkinson's disease	4.47e-06	0.000275	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—Parkinson's disease	4.37e-06	0.000269	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.29e-06	0.000264	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COMT—Parkinson's disease	3.8e-06	0.000234	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.78e-06	0.000233	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.77e-06	0.000232	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—INS—Parkinson's disease	3.73e-06	0.00023	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.73e-06	0.000229	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.58e-06	0.00022	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.47e-06	0.000214	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.33e-06	0.000205	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.07e-06	0.000189	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—Parkinson's disease	2.86e-06	0.000176	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—INS—Parkinson's disease	2.44e-06	0.00015	CbGpPWpGaD
